Extreme Networks, Inc. — Form 10-Q Summary
Reporting period: Fiscal second quarter and six months ended December 31, 2013. Comparisons are with the corresponding periods ended December 31, 2012. Enterasys results are consolidated from its October 31, 2013 acquisition, so reported year-over-year growth is not fully comparable.
Business context and reporting period
Extreme Networks develops and sells networking infrastructure equipment and services. On October 31, 2013, it acquired privately held Enterasys Networks for $180.0 million, net of cash acquired. Management described the combined company as serving more than 12,000 customers, with expanded wired and wireless networking, security, and support offerings.
Financial results and liquidity
| Metric | Three months ended Dec. 31, 2013 | Prior-year quarter | Six months ended Dec. 31, 2013 | Prior-year six months |
|---|---|---|---|---|
| Revenue | $146.6 million | $75.6 million | $222.5 million | $151.7 million |
| Gross profit | $69.8 million | $40.7 million | $113.6 million | $80.7 million |
| Gross margin | 47.7% | 53.9% | 51.0% | 53.2% |
| Operating income (loss) | $(13.8) million | $(3.8) million | $(13.4) million | $9.8 million |
| Net income (loss) | $(16.0) million | $(4.2) million | $(16.0) million | $8.7 million |
| Basic and diluted EPS | $(0.17) | $(0.04) | $(0.17) | $0.09 |
- Quarterly product revenue rose 97.6% to $119.1 million; service revenue rose 80.0% to $27.5 million. Management attributed much of the growth to Enterasys.
- Quarterly product gross margin fell to 43.8% from 51.3%. The filing cites higher acquired-business costs, a $9.2 million inventory step-up charge, and $2.7 million of increased developed-technology amortization. Service margin was 64.2%, versus 64.5%.
- Operating expenses were $83.6 million in the quarter, including $8.7 million of acquisition and integration costs and $3.8 million of intangible amortization. The company expects integration costs to continue for the next two years.
- Six-month operating cash flow was negative $4.9 million, compared with positive $8.1 million a year earlier. Investing cash flow was negative $127.0 million, including the $180.0 million acquisition payment, partly offset by investment sales and maturities. Financing provided $104.0 million, including $100.0 million of new borrowings.
- Cash, cash equivalents, and investments totaled $112.0 million at December 31, down from $205.6 million at June 30. Working capital was $75.7 million, down from $96.3 million. Management said cash and investments plus $25.0 million of revolver availability should fund principal cash needs for at least 12 months.
- Total debt was approximately $99.2 million: a $65.0 million term loan and $35.0 million drawn on a $60.0 million revolving facility, net of scheduled repayment. The facilities mature in 2018, are secured by substantially all company assets, and carry financial covenants; the company reported compliance.
Material changes versus the prior comparable period
- Reported revenue nearly doubled in the quarter, primarily reflecting the acquisition; Enterasys contributed $70.1 million of revenue and $1.2 million of operating income to the six-month consolidated results.
- Quarterly gross margin declined by 6.2 percentage points, and the company’s quarterly operating and net losses widened. Six-month results also shifted from profit to loss; the prior-year period included an $11.5 million gain on sale of facilities.
- Assets increased to $517.5 million from $311.4 million at June 30, including $57.9 million of goodwill and $109.1 million of net intangible assets recognized or assumed in connection with Enterasys.
- Accounts receivable and inventory increased substantially from June 30, to $94.3 million and $62.9 million, respectively; management cited acquisition-related working-capital needs and inventory timing.
Outlook, commentary, risks, and contingencies
- No specific revenue, earnings, or margin guidance is provided. Management’s stated priorities include expanding research and development, integrating Enterasys, maintaining both companies’ product roadmaps, and strengthening customer support and channel partnerships.
- Acquisition purchase accounting remains provisional, with final valuations, post-close adjustments, and tax analysis pending. The unaudited pro forma presentation reports quarterly revenue of $159.9 million and net loss of $55.1 million, and six-month revenue of $321.8 million and net loss of $51.7 million; the filing cautions that these figures are not necessarily indicative of future results.
- Key disclosed risks include integration execution and costs, competitive pricing and margin pressure, demand and forecasting volatility, reliance on contract manufacturers and limited-source components, and the ability to achieve profitability. The company had $63.2 million of non-cancelable inventory purchase commitments, expected to be honored within 12 months.
- Patent cases involving Relay IP (against Extreme and Enterasys) and ReefEdge (assumed with Enterasys) remain pending. The company denies the Relay IP claims and states it cannot estimate a reasonably possible loss or range for current proceedings.
- Management reported effective disclosure controls and internal control over financial reporting, but excluded Enterasys from the internal-control assessment during the permitted integration period. Enterasys represented approximately 48% of quarterly sales and 26% of total assets.
Important facts for investors to verify
- How much of reported revenue growth reflects sustainable combined-company demand versus acquisition timing and consolidation?
- Whether integration costs, inventory step-up effects, and acquired-asset amortization continue to pressure margins, and whether anticipated synergies materialize.
- Whether receivables, inventory, and operating cash flow improve, and whether the company maintains adequate liquidity and compliance with secured-debt covenants.
- Final Enterasys purchase-price allocation, including goodwill, intangible valuations, and tax treatment; also investigate the drivers of the unusually large pro forma net loss.
- Developments in the disclosed patent litigation, component supply and purchase commitments, and the integration of Enterasys financial controls.